Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infuzia is a leading Ukrainian pharmaceutical company specializing in the development and manufacture of high-quality infusion solutions and medical products. Established in 2001 on the foundation of a historic drug manufacturing site in Vinnytsia, the company produces over 50 types of infusion solutions, including electrolytes, plasma substitutes, and anti-infectives. Infuzia operates modern, GMP-certified manufacturing facilities and distributes its products across Ukraine and CIS countries. In addition to traditional small-molecule infusions, the company collaborates on specialized biological products, such as the polyvalent bacteriophage preparation Pyofag.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infuzia.